| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d77ccbb16d44b55d65f8656d42a626ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50 |
| filingDate |
2002-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_527131ed482a3b6eae683036670666a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8596faa928b23d10736a8c8f65a02565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_167a3eb850b740eafe523b8181385c4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f78b9d260d6ae4242e8a2ae1de7d43b1 |
| publicationDate |
2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-RE38629-E |
| titleOfInvention |
Solid oral dosage form comprising a combination of metformin and glibenclamide |
| abstract |
The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009069437-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007032769-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005260274-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005271737-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7767249-B2 |
| priorityDate |
1998-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |